Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion: identification of myocardial risk area and infarct size in the canine model of ischemia

Department of Internal Medicine, Department of Veterans Affairs Medical Center, Dallas, Texas, USA.

OBJECTIVES. This study assessed the accuracy of 2% dodecafluoropentane (EchoGen), an intravenous echocardiographic contrast agent, in identifying myocardial area at risk and infarct size in the canine model of myocardial ischemia. BACKGROUND. Myocardial contrast echocardiography allows determination of myocardial area at risk and infarct size but requires intracoronary injection in humans. The development of agents that can be delivered by peripheral intravenous injection could enable bedside myocardial contrast echocardiographic assessment of risk area, infarct size and reperfusion. METHODS. Two protocols were used. Protocol 1 assessed the accuracy of myocardial contrast echocardiography using intravenous dodecafluoropentane in defining myocardial area at risk and infarct size in the canine model of regional myocardial ischemia versus gross pathologic specimens stained with monastral blue to determine area at risk and triphenyltetrazolium chloride to determine the area of necrosis. Protocol 2 assessed the effects of repeated injections of dodecafluoropentane (0.5 ml/kg body weight, four doses 30 min apart or eight doses 10 min apart) on myocardial blood flow and hemodynamic variables. RESULTS. Myocardial contrast echocardiography accurately defined area at risk and infarct size (r = 0.96 vs. triphenyltetrazolium chloride). Myocardial blood flow remained stable after multiple serial injections of dodecafluoropentane. However, a significant increase in pulmonary artery pressure and pulmonary vascular resistance, along with a decrease in arterial oxygen saturation and cardiac output, was seen in dogs that received eight injections at 10-min intervals. CONCLUSIONS. Myocardial contrast echocardiography using intravenous dodecafluoropentane accurately defined myocardial area at risk and infarct size. Hemodynamic variables and regional myocardial blood flows remained stable when dodecafluoropentane was injected at 30-min intervals for up to four doses; more frequent administration led to cardiopulmonary deterioration. Dodecafluoropentane offers the potential for reliable, noninvasive assessment of reperfusion after therapeutic interventions.

This article has been cited by other articles:

				T. Sakuma, J. Sklenar, H. Leong-Poi, N. C. Goodman, D. K. Glover, and S. Kaul Molecular Imaging Identifies Regions with Microthromboemboli During Primary Angioplasty in Acute Coronary Thrombosis J. Nucl. Med., July 1, 2004; 45(7): 1194 - 1200. [Abstract] [Full Text] [PDF]

				A. Yano, H. Ito, K. Iwakura, R. Kimura, K. Tanaka, A. Okamura, S. Kawano, T. Masuyama, and K. Fujii Myocardial contrast echocardiography with a new calibration method can estimate myocardial viabilityin patients with myocardial infarction J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1799 - 1806. [Abstract] [Full Text] [PDF]

				H. Kunichika, B. Peters, B. Cotter, H. Masugata, N. Kunichika, P. L. Wolf, and A. N. DeMaria Visualization of risk-area myocardium as a high-intensity, hyperenhanced "hot spot" by myocardial contrast echocardiography following coronary reperfusion: Quantitative analysis J. Am. Coll. Cardiol., August 6, 2003; 42(3): 552 - 557. [Abstract] [Full Text] [PDF]

				N. G. Fisher, J. P. Christiansen, A. Klibanov, R. P. Taylor, S. Kaul, and J. R. Lindner Influence of microbubble surface charge on capillary transit and myocardial contrast enhancement J. Am. Coll. Cardiol., August 21, 2002; 40(4): 811 - 819. [Abstract] [Full Text] [PDF]

				S. t. Lafitte, A. Higashiyama, H. Masugata, B. Peters, M. Strachan, O. i L. Kwan, and A. N. DeMaria Contrast echocardiography can assess risk area and infarct size during coronary occlusion and reperfusion: experimental validation J. Am. Coll. Cardiol., May 1, 2002; 39(9): 1546 - 1554. [Abstract] [Full Text] [PDF]

				P Andrassy, M Zielinska, R Busch, A Schomig, and C Firschke Myocardial blood volume and the amount of viable myocardium early after mechanical reperfusion of acute myocardial infarction: prospective study using venous contrast echocardiography Heart, April 1, 2002; 87(4): 350 - 355. [Abstract] [Full Text] [PDF]

				N. G. Fisher, J. P. Christiansen, H. Leong-Poi, A. R. Jayaweera, J. R. Lindner, and S. Kaul Myocardial and microcirculatory kinetics of BR14, a novel third-generation intravenous ultrasound contrast agent J. Am. Coll. Cardiol., February 6, 2002; 39(3): 530 - 537. [Abstract] [Full Text] [PDF]

				M. P. Coggins, J. Sklenar, D. E. Le, K. Wei, J. R. Lindner, and S. Kaul Noninvasive Prediction of Ultimate Infarct Size at the Time of Acute Coronary Occlusion Based on the Extent and Magnitude of Collateral-Derived Myocardial Blood Flow Circulation, November 13, 2001; 104(20): 2471 - 2477. [Abstract] [Full Text] [PDF]

				M. L. Main, A. Magalski, N. K. Chee, M. M. Coen, D. G. Skolnick, and T. H. Good Full-motion pulse inversion power Doppler contrast echocardiography differentiates stunning from necrosis and predicts recovery of left ventricular function after acute myocardial infarction J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1390 - 1394. [Abstract] [Full Text] [PDF]

				H. Kamihata, H. Matsubara, T. Nishiue, S. Fujiyama, Y. Tsutsumi, R. Ozono, H. Masaki, Y. Mori, O. Iba, E. Tateishi, et al. Implantation of Bone Marrow Mononuclear Cells Into Ischemic Myocardium Enhances Collateral Perfusion and Regional Function via Side Supply of Angioblasts, Angiogenic Ligands, and Cytokines Circulation, August 28, 2001; 104(9): 1046 - 1052. [Abstract] [Full Text] [PDF]

				O Kamp, W Lepper, J.-L Vanoverschelde, B.C Aeschbacher, D Rovai, P Assayag, P Voci, Y Kloster, A Distante, and C.A Visser Serial evaluation of perfusion defects in patients with a first acute myocardial infarction referred for primary PTCA using intravenous myocardial contrast echocardiography Eur. Heart J., August 2, 2001; 22(16): 1485 - 1495. [Abstract] [PDF]

				C. Teupe, M. Takeuchi, J. Yao, E. Avelar, and N. Pandian Detection of Viable Myocardium by Transvenous Myocardial Contrast Echocardiography Using Harmonic Power Doppler : Canine Model of Acute Coronary Occlusion and Reperfusion Chest, August 1, 2001; 120(2): 567 - 572. [Abstract] [Full Text] [PDF]

				U. Sechtem Imaging myocardial area at risk and final infarct size Eur. Heart J. Suppl., June 1, 2001; 3(suppl_C): C36 - C46. [PDF]

				K. Ohmori, B. Cotter, E. Leistad, V. Bhargava, P. L. Wolf, K. Mizushige, and A. N. DeMaria Assessment of Myocardial Postreperfusion Viability by Intravenous Myocardial Contrast Echocardiography : Analysis of the Intensity and Texture of Opacification Circulation, April 17, 2001; 103(15): 2021 - 2027. [Abstract] [Full Text] [PDF]

				E. Leistad, K. Ohmori, T. A. Peterson, G. Christensen, and A. N. DeMaria Quantitative assessment of myocardial perfusion during graded coronary artery stenoses by intravenous myocardial contrast echocardiography J. Am. Coll. Cardiol., February 1, 2001; 37(2): 624 - 631. [Abstract] [Full Text] [PDF]

				W. Lepper, R. Hoffmann, O. Kamp, A. Franke, C. C. de Cock, H. P. Kuhl, G. T. Sieswerda, J. v. Dahl, U. Janssens, P. Voci, et al. Assessment of Myocardial Reperfusion by Intravenous Myocardial Contrast Echocardiography and Coronary Flow Reserve After Primary Percutaneous Transluminal Coronary Angiography in Patients With Acute Myocardial Infarction Circulation, May 23, 2000; 101(20): 2368 - 2374. [Abstract] [Full Text] [PDF]

				M. Scherrer-Crosbie, W. Steudel, R. Ullrich, P. R. Hunziker, N. Liel-Cohen, J. Newell, J. Zaroff, W. M. Zapol, and M. H. Picard Echocardiographic determination of risk area size in a murine model of myocardial ischemia Am J Physiol Heart Circ Physiol, September 1, 1999; 277(3): H986 - H992. [Abstract] [Full Text] [PDF]

				T. Yasu, G. W. Schmid-Schonbein, B. Cotter, and A. N. DeMaria Flow dynamics of QW7437, a new dodecafluoropentane ultrasound contrast agent, in the microcirculation: Microvascular mechanisms for persistent tissue echo enhancement J. Am. Coll. Cardiol., August 1, 1999; 34(2): 578 - 586. [Abstract] [Full Text] [PDF]

				T. Sakuma, Y. Hayashi, K. Sumii, M. Imazu, and M. Yamakido Prediction of short- and intermediate-term prognoses of patients with acute myocardial infarction using myocardial contrast echocardiography one day after recanalization J. Am. Coll. Cardiol., October 1, 1998; 32(4): 890 - 897. [Abstract] [Full Text] [PDF]

				L. Galiuto, A. N. DeMaria, K. May-Newman, U. del Balzo, K. Ohmori, V. Bhargava, S. F. Flaim, and S. Iliceto Evaluation of dynamic changes in microvascular flow during ischemia-reperfusion by myocardial contrast echocardiography J. Am. Coll. Cardiol., October 1, 1998; 32(4): 1096 - 1101. [Abstract] [Full Text] [PDF]

				P. A. Grayburn, J. L. Weiss, T. C. Hack, E. Klodas, J. S. Raichlen, M. A. Vannan, A. L. Klein, D. W. Kitzman, S. G. Chrysant, J. L. Cohen, et al. Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms J. Am. Coll. Cardiol., July 1, 1998; 32(1): 230 - 236. [Abstract] [Full Text] [PDF]

				F. S. Villanueva, G. Camarano, S. Ismail, N. C. Goodman, J. Sklenar, and S. Kaul Coronary Reserve Abnormalities in the Infarcted Myocardium: Assessment of Myocardial Viability Immediately Versus Late After Reflow by Contrast Echocardiography Circulation, August 15, 1996; 94(4): 748 - 754. [Abstract] [Full Text]